MS8709 | MedChemExpress (MCE)

MS8709 (10), a potential anticancer therapeutic, is a first-in-class G9a/GLP PROTAC degrader. MS8709 (10) is based on G9a/GLP inhibitor UNC0642 and recruits the von Hippel Lindau (VHL) E3 ligase (Red: G9a/GLP inhibitor UNC0642; Blue: VHL ligand; Black: linker)^[1].

Price Not Available 1 mg MS8709 | MedChemExpress (MCE) Supplier Page

Trivial name	MS8709
Catalog Number	HY-162362
Research Area	Cancer
Purity	≥98.0%
SMILES	O=C([C@H]1N(C([C@@H](NC(CCCCCCCCCCCNC(CCCN2CCC(NC3=C4C=C(OC)C(OCCCN5CCCC5)=CC4=NC(N6CCC(F)(F)CC6)=N3)CC2)=O)=O)C(C)(C)C)=O)C[C@H](O)C1)NCC7=CC=C(C8=C(C)N=CS8)C=C7
Size	1 mg
Supplier Page	https://www.medchemexpress.com/ms8709.html